yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q35528797-C87B317E-1106-4435-97F7-E8FDE552AC78
Q35528797-C87B317E-1106-4435-97F7-E8FDE552AC78
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35528797-C87B317E-1106-4435-97F7-E8FDE552AC78
Short commentary on empagliflozin and its potential clinical impact
P2860
Q35528797-C87B317E-1106-4435-97F7-E8FDE552AC78
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35528797-C87B317E-1106-4435-97F7-E8FDE552AC78
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
502c7850572ed135cc87a7b6baf67775cfed1da4
P2860
Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease.